The importance of HIFAR to nuclear medicine
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Australian Nuclear Association
Abstract
Since its official opening on 26 January 1960, the HIFAR research reactor operated by the Australian Nuclear Science and Technology Organisation (ANSTO) at Lucas Heights near Sydney has been used to support an expanding nuclear medicine market. HIFAR has characteristics which make it very suitable for this role and the effect has been to make ANSTO the dominant supplier of reactor-based radiopharmaceuticals in Australia and a significant exporter. While HIFAR has capacity to support limited increased production, its future requires government decisions. The author concluded that the absence of an operational research reactor in Australia and the lack of another local source of neutrons could directly affect the practice of nuclear medicine in the country and the level of presently increasing exports.
Description
Physical copy held by ANSTO Library at DDC: 621.48/9
Keywords
HIFAR Reactor, ANSTO, Australian organizations, Nuclear medicine, Radiopharmaceuticals, Production, Neutrons, Bromine 82, Chromium 51, Commercialization, Copper 64, Exports, Isotope production, Market, Neutron source facilities, Radioisotope generators, Technetium 99, Ytterbium, Years living radioisotopes
Citation
Wood, N. R. (1997). The importance of HIFAR to nuclear medicine. Paper presented to ANA 97 "Second Conference on Nuclear Science & Engeering in Australia, Sydney, 16-17 October 1997. In ANA 97: second conference on nuclear science & engineering in Australia, 1997, Millennium Sydney, 16-17 October 1997. Conference handbook, (pp. 52-54), Canberra, ACT: Australian Nuclear Association.